// App-Quantinova.ai

: Sodium-Glucose Cotransporter-2 Inhibitors Are Associated With Lower Risks of Hospitalization for Heart Failure and All-Cause Mortality in Patients With Diabetes Mellitus and Cancer

Researchers

Presenter

  • Cho Han Chiang

Principal Investigators

  • Cho Hsien Chiang

  • Kevin Ma

  • Chun-Yu Peng

  • HSIA yuanping

  • Chuan-Sheng Horng

  • CHENG-YING CHEN

  • Yu-Cheng Chang

  • Xin Ya See

  • Yuan-Jen Chen

  • Shih-Syuan Wang

  • Giselle A Suero Abreu

  • Linda R Peterson

  • Paaladinesh Thavendiranathan

  • Philippe Armand

  • Cheng-Ming Peng

  • Her-Shyong Shiah

  • Tomas G Neilan

Medical Centers

  • Mount Auburn Hospital, Cambridge, MA

  • Cathay General Hospital, Taipei, Taiwan

  • MASS GENERAL HOSPITAL, Boston, MA

  • Taipei Tzu Chi Hosp, Taipei, Taiwan

  • Massachusetts General Hospital, Boston, MA

  • Dana-Farber Cancer Institute, Boston, MA

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Toronto General Hospital-UHN, Toronto , Canada

  • National Taiwan University College of Medicine, Taipei, Taiwan

  • Dept of General Div, Taipei Tzu Chi Hosp, Taipei, Taiwan

  • University of Pennsylvania, Philadelphia, PA

  • Chung Shan Medical University, Taichung, Taiwan

  • WASHINGTON U IN ST LOUIS, Saint Louis, MO

Locations

  • United States

  • Taiwan

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

Disease

  • Type 2 diabetes mellitus

  • Myocardial infarction

  • Diabetes

  • Ischemic stroke

  • Congestive heart failure

  • Solid malignancies

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved